Währungen / NVO
NVO: Novo Nordisk A/S
74.02
USD
0.54
(0.72%)
Der Wechselkurs von NVO hat sich für heute um -0.72% verändert. Im Laufe des Tages wurde das Instrument von einem Tief von 73.70 bis zu einem Hoch von 74.81 gehandelt.
Verfolgen Sie die Novo Nordisk A/S-Dynamik. Mit Echtzeit-Kursen können Sie schnell auf Marktveränderungen reagieren. Indem Sie zwischen verschiedenen Zeitrahmen wechseln, können Sie Kurstrends und -dynamik nach Minuten, Stunden, Tagen, Wochen und Monaten verfolgen. Nutzen Sie diese Informationen, um Marktveränderungen vorherzusagen und fundierte Handelsentscheidungen zu treffen.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
NVO News
- Investing Factbox-Fat, not muscle: Drugmakers in race for next weight-loss breakthrough
- Investing Novo Nordisk stock rating reiterated at Buy by TD Cowen
- Investing US judge upholds FDA’s removal of Ozempic, Wegovy from drug shortage list
- Benzinga Scholar Rock's Atrophy Drug When Combined With Eli Lilly's Zepbound Shows Around 55% Better Muscle Preservation In Weight Loss Study - Scholar Rock Holding (NASDAQ:SRRK)
- Investing KeyBanc reiterates West Pharmaceutical stock rating on GLP-1 growth
- Investing Eli Lilly stock price target maintained at $1,100 by Bernstein on Verve deal
- The Motley Fool Novo Nordisk Just Improved Its Weight-Management Pipeline: Is the Stock a Buy?
- Investing LifeMD price target raised to $18 from $15 on GLP-1 demand at BTIG
- Investing Eli Lilly acquisition of Verve signals renewed interest in gene editing
- Investing UBS reiterates Biogen stock neutral rating despite recent rally
- Seeking Alpha Eli Lilly: The Buy Case Gets Stronger (Rating Upgrade) (NYSE:LLY)
- The Motley Fool Why Novo Nordisk Stock Sank by Nearly 4% Today
- Investing LifeMD Announces Annual Meeting Results
- TipRanks Eli Lilly Stock (LLY) Sinks as Novo Nordisk Is Again Europe’s Most Valuable Company - TipRanks.com
- Seeking Alpha 2 Reasons To Double Down On Hims & Hers Ahead Of August (NYSE:HIMS)
- Benzinga Ozempic Patent Expires In Canada After Novo Nordisk Fails To Pay $450 Fee: 'It's The Second-Largest Semaglutide Market In The World,' Says Sandoz CEO Richard Saynor - Sandoz Group (OTC:SDZNY), Novo Nordisk (NYSE:NVO)
- Investing Eli Lilly stock price target maintained at $1,100 on strong Zepbound sales
- The Motley Fool 3 Growth Stocks You Can Buy Right Now Without Any Hesitation
- Investing Prothena partner Roche advances Parkinson’s drug to phase 3
- MarketWatch Israel-Iran conflict poses three challenges for stocks that could slam market by up to 20%, warns RBC
- Seeking Alpha Novo Nordisk: The Strength To Withstand Challenges (NYSE:NVO)
- MarketWatch The story of how Novo Nordisk will lose billions because it didn’t pay a couple of hundred dollars
- Seeking Alpha Client Update June 2025: Long-Term Value And Growth Potential
- The Motley Fool 1 Growth Stock Down 9% to Buy Right Now
Tagesspanne
73.70
74.81
Jahresspanne
57.00
145.99
- Vorheriger Schlusskurs
- 74.31
- Eröffnung
- 74.56
- Bid
- 74.02
- Ask
- 74.32
- Tief
- 73.70
- Hoch
- 74.81
- Volumen
- 10.702 K
- Tagesänderung
- -0.72%
- Monatsänderung
- 3.14%
- 6-Monatsänderung
- -15.80%
- Jahresänderung
- -48.45%
19 Juni, Donnerstag
00:00
USD
Juneteenth, nationaler Unabhängigkeitstag
- Akt
- Erw
- Vorh